Note: The date of approval is approximate in some cases (e.g. date of publication)

carvedilol

Date approved: 00.08.98

Coreg Tab, SmithKline Beecham: Malaysia

tablets 3.125 mg, 6.25 mg, 12.5 mg, 25 mg

ß-adrenoreceptor antagonist

New indications: Adjunctive therapy of patients with symptomatic mild to moderate congestive heart failure.

enoxaparin sodium Date approved: 00.08.98

Clexane, Rhone-Poulenc Rorer: Malaysia

[pre-filled syringes] 60 mg/0.6 mL, 50 mg/0.8 mL, 100 mg/mL

low-molecular weight heparin antithrombotic agent

New indications: Treatment of established deep vein thrombosis.

methylprednisolone aceponate

Date approved: 02.06.98

Advantan, Schering: Germany

ointment, cream 1 mg/g (0.1%)

anti-inflammatory agent

New indications: Treatment of endogenous eczema (atopic dermatitis, neurodermatitis) contact eczema, degenerative dyshidrotic eczema vulgaris, neurodermatitis in children.

pamidronate Date approved: 00.08.98

Aredia, Novartis: Malaysia

powder for injection 60 mg/vial, 90 mg/vial

inhibitor of osteoclastic activity

New indication: Osteolysis in multiple myeloma.